| 1 |
22635088 | Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders. | 2012 |
1 |
| 2 |
16019380 | Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine. | 2005 Jun |
1 |
| 3 |
16311416 | Treatment of pituitary tumors: dopamine agonists. | 2005 Oct |
1 |
| 4 |
12660266 | An investigation of the effectiveness of testosterone implants in combination with the prolactin inhibitor quinagolide in the suppression of spermatogenesis in men. | 2003 Apr |
1 |
| 5 |
11836053 | Spectrophotometric determination of clobetasol propionate, halobetasol propionate, quinagolide hydrochloride, through charge transfer complexation. | 2002 Mar 1 |
1 |
| 6 |
12010287 | MR imaging of pituitary adenomas treated with the prolactin inhibitor quinagolide. | 2002 Mar |
2 |
| 7 |
10931080 | The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. | 2000 Jul |
2 |
| 8 |
10962898 | [Treatment of hyperprolactinemic anovulation with the dopamin-agonist quinagolide]. | 2000 Jul 16 |
3 |
| 9 |
11084391 | Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse. | 2000 Nov |
4 |
| 10 |
9893701 | [Treatment of pituitary adenoma]. | 1998 Dec 12 |
1 |
| 11 |
9258810 | Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma. | 1997 May |
2 |
| 12 |
8921822 | Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy. | 1996 Oct |
3 |
| 13 |
9039343 | In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand. | 1996 Dec |
1 |
| 14 |
7889620 | Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine. | 1994 Dec |
5 |
| 15 |
7911813 | A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients. | 1994 Jan |
1 |
| 16 |
7906538 | Ophthalmic results in patients with macroprolactinomas treated with a new prolactin inhibitor CV 205-502. | 1993 Dec |
2 |
| 17 |
8098604 | Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study. | 1993 Apr |
3 |